Research output per year
Research output per year
Personal profile
Research interests
Developing new and better treatment approaches to lymphoma and chronic lymphocytic leukemia.
Clinical interests
Lymphoma, CLL
Fingerprint
Dive into the research topics where Brad Kahl is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma
Cortese, M. J., Wei, W., Cerdeña, S., Watkins, M. P., Olson, M., Jodon, G., Kaiser, J., Haverkos, B., Hughes, M. E., Namoglu, E., Grover, N. S., Snow, A., Orellana-Noia, V., Rainey, M., Sohail, M., Rudoni, J., Portell, C., Voorhees, T., Landsburg, D. J., Kamdar, M., & 2 others, 2023, In: Leukemia and Lymphoma. 64, 1, p. 107-118 12 p.Research output: Contribution to journal › Article › peer-review
-
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma
Desai, S. H., Spinner, M. A., David, K., Bachanova, V., Goyal, G., Kahl, B., Dorritie, K., Azzi, J., Kenkre, V. P., Arai, S., Chang, C., Fusco, B., Sumransub, N., Hatic, H., Saba, R., Ibrahim, U., Harris, E. I., Shah, H., Murphy, J., Ansell, S., & 10 others, Mar 2023, In: American journal of hematology. 98, 3, p. 464-471 8 p.Research output: Contribution to journal › Article › peer-review
-
Clinical outcomes in patients relapsed/refractory after ≥2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis
Kanters, S., Ball, G., Kahl, B., Wiesinger, A., Limbrick-Oldfield, E. H., Sudhindra, A., Snider, J. T. & Patel, A. R., Dec 2023, In: BMC Cancer. 23, 1, 74.Research output: Contribution to journal › Article › peer-review
Open Access -
Is local review of positron emission tomography scans sufficient in diffuse large B-cell lymphoma clinical trials? A CALGB 50303 analysis
Torka, P., Pederson, L. D., Knopp, M. V., Poon, D., Zhang, J., Kahl, B. S., Higley, H. R., Kelloff, G., Friedberg, J. W., Schwartz, L. H., Wilson, W. H., Leonard, J. P., Bartlett, N. L., Schöder, H. & Ruppert, A. S., Apr 2023, In: Cancer medicine. 12, 7, p. 8211-8217 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Management of Diffuse Large B-Cell Lymphoma: Are We Getting Smarter?
Kahl, B. S., Feb 1 2023, In: Journal of Clinical Oncology. 41, 4, p. 724-726 3 p.Research output: Contribution to journal › Editorial
Open Access